CD8A and neoplasm: GM-CSF also increased immunoglobulin production, DC, CD4+, and CD8+ T cell counts, and tumor-specific lymphocyte cytotoxicity when administered together with the MB49 bladder cancer stem cell vaccine in a mouse model (110, 111).